Metabolism - Clinical and Experimental
Volume 59, Issue 9 , Pages 1294-1299, September 2010

Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitus

Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan

Received 10 February 2009; accepted 1 December 2009. published online 13 January 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 A part of this report has already been presented at The 40th European Association for the Study of Diabetes (EASD) Annual Meeting, Munich, Germany, 2004.

PII: S0026-0495(09)00508-3

doi:10.1016/j.metabol.2009.12.004

Metabolism - Clinical and Experimental
Volume 59, Issue 9 , Pages 1294-1299, September 2010

Article Tools

* Image Usage & Resolution